 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Current Price	$52.48
Prev Close	$52.49
Open	$52.47
Dividend Yield	0.00%
50-Day Moving Average	$43.93
Beta	1.37
Avg. Volume	3.65M
PE Ratio	N/A

52-Week High	$52.53
52-Week Low	$12.58
Market Capitalization	$6.24B
EPS	-$2.12
Price to Book	15.74
Revenue Per Employee	$254,847.46
Enterprise Value/EBITDA	-14.55

MNTA Momenta Pharmaceuticals Inc.

About

Feed

Fundamentals

News